Skip to main content

Table 2 Comparison of laboratory data of patients with KDSS or KD

From: Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition

 

KDSS (n = 27)

KD (n = 43)

P value

WBC count (×109/L)

19.04 ± 8.53

13.12 ± 5.22

0.002a

PMNs (%)

79.44 ± 17.56

60.76 ± 14.34

< 0.001 a

Hb(g/L)

99.37 ± 12.69

110.44 ± 10.17

< 0.001 a

Platelet count (× 109/L)

277(57–531)

355(150–629)

0.056 a

ESR (mm/h)

101(24–140)

67(6–135)

0.041b

ESR > 40 mm/h,no(%)

25(92.59)

37(86.05)

0.472c

CRP (mg/dl)

137.15 ± 54.80

76.11 ± 50.66

< 0.001 a

Albumin (mmol/L)

30.12 ± 6.54

36.28 ± 3.73

< 0.001 a

Serum sodium concentration (mmol/L)

132.85 ± 3.73

135.62 ± 3.68

0.004 a

Serum potassium concentration (mmol/L)

3.38 ± 0.50

3.81 ± 0.46

0.001 a

ALT (U/L)

53 (12–415)

18 (10–477)

0.014b

AST (U/L)

43 (21–472)

35 (18–448)

0.080b

Lactic acid concentration (mmol/l)

1.96 ± 0.79

2.14 ± 0.81

0.372 a

Creatinine(μmol/L)

47.5(34–456)

35(25–58)

< 0.001 b

BUN(mmol/L)

5(2–16)

2.62(1.38–4.84)

< 0.001b

CK-MB(U/L)

34.12 ± 16.05

20.01 ± 8.46

< 0.001a

Triglyceride(mmol/L)

1.78 ± 0.60

1.30 ± 0.51

0.001 a

Blood amylase (U/L)

54.3(11.9–404.8)

27.8 (7.1–75.5)

0.087b

Fibrinogen(g/L)

4(2–7)

4.46(3.87–5.12)

0.875b

D-dimer(mg/L)

3.45(1.13–7.88)

1.16(0.36–1.43)

0.001b

PCT(ng/ml)

2.33(0.46–19)

0.56(0.001–21.88)

< 0.001b

  1. aTwo-sample t test
  2. bManne-Whitney U test
  3. cFisher’s exact test